As of the end of October, Midea Group Co., Ltd (000333.SZ) has cumulatively used repurchase funds amounting to 9.575 billion yuan.
Midea Group (000333.SZ) announced that the company's share buyback progress, with a planned buyback of 15-30 billion A shares...
Midea Group Co., Ltd (000333.SZ) announced the progress of share repurchase. As of October 31, 2025, for the 15-30 billion A-share repurchase plan, the company has repurchased a total of 20.564598 million A-shares through centralized bidding trading, accounting for 0.2676% of the company's current total share capital, with a total amount paid of 15.1 billion yuan (excluding transaction costs). For the 50-100 billion A-share repurchase plan, as of October 31, 2025, the company has repurchased a total of 110 million A-shares through centralized bidding trading, accounting for 1.4372% of the company's current total share capital, with a total amount paid of 80.65 billion yuan (excluding transaction costs).
Related Articles

Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.
Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


